Diagnostics and data - how TempusAI is tackling the search for a cure for cancer
In an previous article, we looked at how the pharmaceutical giants are gearing up to use AI to take on the blight of cancer. All of them have made advances down this route and all have expectations of great things to come.
But away from those multi-national, broad reach firms, there are cancer specialist firms, most notably TempusAI, set up ten years ago with the aim of using AI to unlock precision medicine. CEO Eric Lefkofsky says:
In order to do that, you basically need two things. You need vast amounts of proprietary data to build models to bring the benefits of AI in healthcare and you need a distribution system to take those insights and deliver them to the hands of physicians and patients. Tempus is unique in that it has both. We have vast amounts of data. We have vast compute and modeling capabilities and a vast distribution...
Copyright of this story solely belongs to diginomica.com. To see the full text click HERE
